Abstract

Radiation exudative pericarditis is a rare (up to 24%) complication of radiation and combination treatment for lymphogranulomatosis and lung cancer. As of now, preference is given to drug management of patients with exudative and adhesive-exudative pericarditis. The experience in treating 27 patients with radiation exudative pericarditis has shown that combined drug treatment with anti-inflammatory drugs from different groups, diuretics, and metabolic and vascular agents results in a reduction or disappearance of fluid in the pericardial cavity in 44% of cases, elimination of the signs of heart failure, improvement in central and systemic hemodynamic parameters, and an increase in the quality of life in patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call